Bovine intestinal alkaline phosphatase - Alloksys Life Sciences

Drug Profile

Bovine intestinal alkaline phosphatase - Alloksys Life Sciences

Alternative Names: bIAP; bovine RESCAP® - Alloksys; bRESCAP

Latest Information Update: 03 Jun 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Alloksys Life Sciences
  • Class Phosphoric monoester hydrolases
  • Mechanism of Action Cytokine modulators; Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Phase III Ischaemia
  • No development reported Rheumatoid arthritis

Most Recent Events

  • 15 Dec 2016 Biomarkers information updated
  • 03 Jun 2016 Bovine intestinal alkaline phosphatase is still in phase III trials for Ischaemia in Belgium and Netherlands
  • 03 Jun 2016 Interim efficacy data from a phase IIIa trial in Ischaemia released by Alloksys before June 2016
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top